Display options
Share it on

Br J Clin Pharmacol. 2021 Feb;87(2):565-576. doi: 10.1111/bcp.14418. Epub 2020 Jul 09.

The pharmacotherapy team: A novel strategy to improve appropriate in-hospital prescribing using a participatory intervention action method.

British journal of clinical pharmacology

Rashudy F Mahomedradja, Kim C E Sigaloff, Jessica K Bekema, Marieke J H J Dekker, David J Brinkman, Marianne A Kuijvenhoven, Marlou L H van Beneden, Birgit I Lissenberg-Witte, Jelle Tichelaar, Michiel A van Agtmael

Affiliations

  1. Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  2. Department of Internal Medicine, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  3. Research and Expertise Center in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.
  4. Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  5. Department of Internal Medicine, Section of Acute Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  6. Department of Epidemiology and Biostatistics, Amsterdam UMC location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

PMID: 32520431 DOI: 10.1111/bcp.14418

Abstract

AIMS: Prescribing medication is a complex process that, when done inappropriately, can lead to adverse drug events, resulting in patient harm and hospital admissions. Worldwide cost is estimated at 42 billion USD each year. Despite several efforts in the past years, medication-related harm has not declined. The aim was to determine whether a prescriber-focussed participatory action intervention, initiated by a multidisciplinary pharmacotherapy team, is able to reduce the number of in-hospital prescriptions containing ≥1 prescribing error (PE), by identifying and reducing challenges in appropriate prescribing.

METHODS: A prospective single-centre before- and after study was conducted in an academic hospital in the Netherlands. Twelve clinical wards (medical, surgical, mixed and paediatric) were recruited.

RESULTS: Overall, 321 patients with a total of 2978 prescriptions at baseline were compared with 201 patients with 2438 prescriptions postintervention. Of these, m456 prescriptions contained ≥1 PE (15.3%) at baseline and 357 prescriptions contained ≥1 PEs (14.6%) postintervention. PEs were determined in multidisciplinary consensus. On some study wards, a trend toward a decreasing number of PEs was observed. The intervention was associated with a nonsignificant difference in PEs (incidence rate ratio 0.96, 95% confidence interval 0.83-1.10), which was unaltered after correction. The most important identified challenges were insufficient knowledge beyond own expertise, unawareness of guidelines and a heavy workload.

CONCLUSION: The tailored interventions developed with and implemented by stakeholders led to a statistically nonsignificant reduction in inappropriate in-hospital prescribing after a 6-month intervention period. Our prescriber-focussed participatory action intervention identified challenges in appropriate in-hospital prescribing on prescriber- and organizational level.

© 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Keywords: clinical pharmacology; medical education; medication errors; medication safety; prescribing

References

  1. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277(4):312-317. - PubMed
  2. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A Framework for Improvement. JAMA. 1999;282(15):1458-1465. - PubMed
  3. Aronson JK, Henderson G, Webb DJ, Rawlins MD. A prescription for better prescribing. BMJ. 2006;333:459-460. - PubMed
  4. Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80(4):808-817. - PubMed
  5. Jagsi R, Kitch BT, Weinstein DF, Campbell EG, Hutter M, Weissman JS. Residents report on adverse events and their causes. Arch Intern Med. 2005;165(22):2607-2613. - PubMed
  6. Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol. 2009;67(6):624-628. - PubMed
  7. Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8:e019101. - PubMed
  8. Organization, G.W.H. Medication Errors - Technical Series on Safer Primary Care; 2016. - PubMed
  9. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, Group, H.S. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890-1896. - PubMed
  10. Warle-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PM, De Smet PA, Dutch H-WTF. Targeting outpatient drug safety: recommendations of the Dutch HARM-wrestling task force. Drug Saf. 2012;35(3):245-259. - PubMed
  11. Pronovost P, Weast B, Schwarz M, et al. Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care. 2003;18(4):201-205. - PubMed
  12. Sturkenboom M. Eindrapport: vervolgonderzoek medicatieveiligheid; 2017. - PubMed
  13. Veeren JC, Weiss M. Trends in emergency hospital admissions in England due to adverse drug reactions: 2008-2015. J Pharm Health Serv Res. 2017;8:5-11. - PubMed
  14. Ahmed F, Ahmed N, Briggs TWR, et al. Can reverse innovation catalyse better value health care? Lancet Glob Health. 2017;5(10):e967-e968. - PubMed
  15. Klopotowska JE, Kuiper R, van Kan HJ, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174. - PubMed
  16. Surgery and Pharmacy in Liaison (SUREPILL) Study Group. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study). Br J Surg. 2015;102:1204-1212. - PubMed
  17. Baum F, MacDougall C, Smith D. Participatory action research. J Epidemiol Community Health. 2006;60:854-857. - PubMed
  18. Norton MI, Mochon D, Ariely D. The IKEA effect: when labor leads to love. J Consum Psychol. 2012;22:453-460. - PubMed
  19. Dollman WB, Leblanc VT, Stevens L, O'Connor PJ, Roughead EE, Gilbert AL. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther. 2005;30(5):425-432. - PubMed
  20. Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with 'non-adherent' patients: a qualitative study. Br J Gen Pract. 2002;52(474):24-32. - PubMed
  21. Sikkens JJ, van Agtmael M, Peters EJG, et al. Behavioral approach to appropriate antimicrobial prescribing in hospitals: the Dutch unique method for antimicrobial stewardship (DUMAS) participatory intervention study. JAMA Intern Med. 2017;177(8):1130-1138. - PubMed
  22. Dean B, Barber N, Schachter M. What is a prescribing error? Qual Health Care. 2000;9(4):232-237. - PubMed
  23. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm. 1991;48(12):2611-2616. - PubMed
  24. Forrey RA, Pedersen CA, Schneider PJ. Interrater agreement with a standard scheme for classifying medication errors. Am J Health Syst Pharm. 2007;64(2):175-181. - PubMed
  25. Wierenga PC, Lie AHL, de Rooij SE, Klazinga NS, Guchelaar HJ, Smorenburg SM. Application of the Bow-tie model in medication safety risk analysis: consecutive experience in two hospitals in the Netherlands. Drug Saf. 2009;32:663-673. - PubMed
  26. Tim Dornan (Principal Investigator), Heathfield DAH, Lewis, P, Miles, J, Taylor, D, Tully M, Wass V.  An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study; 2009. - PubMed
  27. van Buul LW, Sikkens JJ, van Agtmael MA, Kramer MH, van der Steen JT, Hertogh CM. Participatory action research in antimicrobial stewardship: a novel approach to improving antimicrobial prescribing in hospitals and long-term care facilities. J Antimicrob Chemother. 2014;69(7):1734-1741. - PubMed
  28. Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of 'deprescribing' with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254-1268. - PubMed
  29. Gleason KM, McDaniel M, Feinglass J, et al. Results of the medications at transitions and clinical handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med. 2010;25(5):441-447. - PubMed
  30. Bos JM, van den Bemt PMLA, Kievit W, et al. A multifaceted intervention to reduce drug-related complications in surgical patients. Br J Clin Pharmacol. 2017;83(3):664-677. - PubMed
  31. Dolovich L, Pottie K, Kaczorowski J, et al. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008;83(6):913-917. - PubMed
  32. Tan EC, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: the pharmacists in practice study (PIPS). Res Social Adm Pharm. 2014;10(4):623-632. - PubMed
  33. Makowsky MJ, Koshman SL, Midodzi WK, Tsuyuki RT. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]. Med Care. 2009;47:642-650. - PubMed
  34. Taylor FW. The principles of scientific management. New York: Harper & Brothers; 1911. - PubMed

MeSH terms

Publication Types